Provides information about the presence of circulating tumour cells, their concentration and immunophenotype, which may help identify their origin.
Cancer
Oncotrace
It is used to provide guidance about a patient’s prognosis, and to help identify the primary tumour when this is unknown.
Research Genetics Cancer Centre, Greece
